StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories cGM (FreeStyle Libre) — Organic / Comparable Sales Growth (%) (%)

Form 8-K Earnings Releases & Form 10-K MD&A ('sales of continuous glucose monitors')

QuarterlyAnnual
Latest, Q3 2026
7.7%
Period ended Sep 30, 2026
Change on a year earlier
-9.5 pts
17.2% in Q3 2025
History
25 quarters
Since Q1 2019
Sources
25
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCGM (FreeStyle Libre) — Organic / Comparable Sales Growth (%) (%)Year on yearSource
Q3 2026Sep 30, 20267.7%-9.5 ptsSEC Filing (0001628280-26-066601) ↗
Q2 2026Jun 30, 20269.5%-10.1 ptsSEC Filing (0001628280-26-048377) ↗
Q1 2026Mar 31, 20267.6%-14.0 ptsSEC Filing (0001628280-26-025365) ↗
Q4 2025Dec 31, 202512.2%-10.6 ptsSEC Filing (0001628280-26-002982) ↗
Q3 2025Sep 30, 202517.2%-3.5 ptsSEC Filing (0001628280-25-045049) ↗
Q2 2025Jun 30, 202519.6%-0.8 ptsSEC Filing (0001628280-25-035135) ↗
Q1 2025Mar 31, 202521.6%-1.7 ptsSEC Filing (0001628280-25-017924) ↗
Q4 2024Dec 31, 202422.8%–SEC Filing (0001628280-25-002092) ↗
Q3 2024Sep 30, 202420.7%-7.8 ptsSEC Filing (0001628280-24-042893) ↗
Q2 2024Jun 30, 202420.4%-4.3 ptsSEC Filing (0001628280-24-032182) ↗
Q1 2024Mar 31, 202423.3%–SEC Filing (0001628280-24-016497) ↗
Q3 2023Sep 30, 202328.5%–SEC Filing (0001628280-23-034544) ↗
Q2 2023Jun 30, 202324.7%-0.9 ptsSEC Filing (0001628280-23-025156) ↗
Q2 2022Jun 30, 202225.6%–SEC Filing (0001104659-22-081006) ↗
Q1 2022Mar 31, 202226.2%–SEC Filing (0001104659-22-047560) ↗
Q4 2021Dec 31, 202136.0%-6.6 ptsSEC Filing (0001104659-22-007648) ↗

Cite this data

StockData. (2026). Abbott Laboratories CGM (FreeStyle Libre) — Organic / Comparable Sales Growth (%) (%), quarterly Q1 2019–Q3 2026 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/cgm-yoy-org

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.